Ramsay Health Care Ltd (OTCPK:RMYHY)

$ 6.85 0 (0%) Market Cap: 6.31 Bil Enterprise Value: 13.35 Bil PE Ratio: 10.55 PB Ratio: 1.83 GF Score: 72/100

Full Year 2024 Ramsay Health Care Ltd Earnings Call Transcript
Aug 29, 2024

$7.42

Earnings
Half Year 2024 Ramsay Health Care Ltd Earnings Call Transcript
Feb 28, 2024

$7.87

Earnings
Ramsay Health Care Ltd Annual Shareholders Meeting Transcript
Nov 27, 2023
Ramsay Health Care Ltd Investor Day Transcript
Nov 10, 2023
Full Year 2023 Ramsay Health Care Ltd Earnings Presentation Transcript
Aug 23, 2023
Q3 2023 Ramsay Health Care Ltd Business Update Presentation Transcript
May 03, 2023
Half Year 2023 Ramsay Health Care Ltd Earnings Presentation Transcript
Feb 22, 2023
Ramsay Health Care Ltd Annual Shareholders Meeting Transcript
Nov 28, 2022
Q1 2023 Ramsay Health Care Ltd Earnings Call Transcript
Nov 10, 2022

$9.5

Earnings
Full Year 2022 Ramsay Health Care Ltd Earnings Call Transcript
Aug 25, 2022

$12.4

Earnings
Half Year 2022 Ramsay Health Care Ltd Earnings Call Transcript
Feb 23, 2022

$11.23

Earnings
Ramsay Health Care Ltd Investor Briefing Day 2 Transcript
Dec 13, 2021
Ramsay Health Care Ltd to Acquire 100% of Elysium Healthcare Transcript
Dec 12, 2021
Ramsay Health Care Ltd Investor Briefing Day 1 Transcript
Dec 09, 2021
Ramsay Health Care Ltd Annual Shareholders Meeting Transcript
Nov 23, 2021
Ramsay Health Care Ltd Trading Update FY22 Transcript
Nov 10, 2021
Full Year 2021 Ramsay Health Care Ltd Earnings Call Transcript
Aug 26, 2021

$12.24

Earnings
Ramsay Health Care Ltd To Consider Recommended Cash Offer To Acquire Spire Healthcare M&A Call Transcript
May 26, 2021
Half Year 2021 Ramsay Health Care Ltd Earnings Call Transcript
Feb 24, 2021

$12.82

Earnings

Full Year 2024 Ramsay Health Care Ltd Earnings Call Transcript

Aug 29, 2024 / 11:30PM GMT

Release Date Price: $7.42

Transcript

Craig McNally

Ramsay Health Care Ltd - Chief Executive Officer, Managing Director, Executive Director

Good morning, everyone, and thank you for joining us today as we present our FY24 results. I'm Craig McNally and I'm joined by Martyn Roberts, our Group Chief Financial Officer. Today, we'll provide an overview of our performance for FY24, followed by an update on our group's strategic direction and outlook.

As we celebrate Ramsay's 60-year anniversary, I'd like to start by thanking our people and clinicians for their ongoing commitment to our patients, delivering on Ramsay's purpose of people caring for people, which has been the backbone of our success over the last 60 years.

Turning to the key takeaways from the year, we've seen activity levels continue to grow with group hospital admissions up 3.4% and a good improvement in activity in Elysium and our primary and allied healthcare activities in Europe. Combined with tariff indexation, we reported 7.3% growth in revenue from patient activity. The growth rate slowed in the second half, reflecting stronger growth in the previous

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.